JTE-907

JTE-907
Legal status
Legal status	CA: Schedule II;
Identifiers
	IUPAC name N-(benzo[1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentyloxy-1,2-dihydroquinoline-3-carboxamide;
CAS Number	282089-49-0 ;
PubChem CID	9867770;
ChemSpider	8043461;
UNII	DAV3Q7SNOL;
CompTox Dashboard (EPA)	DTXSID001010010 ;
ECHA InfoCard	100.209.196
Chemical and physical data
Formula	C24H26N2O6
Molar mass	438.480 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES c4c3OCOc3ccc4CNC(=O)c(cc2ccc1OC)c(=O)[nH]c2c1OCCCCC;
	InChI InChI=1S/C24H26N2O6/c1-3-4-5-10-30-22-19(29-2)9-7-16-12-17(24(28)26-21(16)22)23(27)25-13-15-6-8-18-20(11-15)32-14-31-18/h6-9,11-12H,3-5,10,13-14H2,1-2H3,(H,25,27)(H,26,28); Key:GRAJFFFXJYFVOC-UHFFFAOYSA-N;
	(verify)

JTE-907 is a drug used in scientific research that acts as a selective CB₂ inverse agonist.^[1]^[2] It has anti-inflammatory effects in animal studies,^[3] thought to be mediated by an interaction between the CB₂ receptor and IgE.^[4]